Scientists at the MRC Laboratory of Medical Sciences (LMS) have discovered a DNA-based “dimmer switch” that regulates the activity of a critical developmental gene, Cdx2. This work could pave the way ...
As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...
Clinical Trials Arena on MSN
Fractyl Health’s GLP-1 gene therapy trial given green light
Fractyl believes its AAV GLP-1 gene therapy is the first of its kind to enter clinical trials.
Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, ...
Contemporary AD systemic selection remains largely preference- and logistics-driven, despite modest EASI-75/EASI-90 response rates with Th2 biologics and JAK inhibitors at 12–16 weeks. The GEP-497 ...
Recent estimates of chronic pain prevalence in the United States indicate that more than 50 million adults (20.5 percent) report experiencing pain on most days or every day (Yong, Mullins, and ...
National Eye Institute (NEI) scientists have found that the way the retina metabolizes glucose directly controls which genes get switched on and off in light-sensing photoreceptors. The findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results